Sunday 11 October 2026 Export all SNY data to Excel Powerpack

Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS fell 90.8%, free cash flow fell 45.1% and total debt rose 8.23%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

40.07 0.16 −0.40%

Follow SNY

Alert me

Market cap: $95.9B
P/E: 21.0×
Fwd P/E: —
Dividend yield: 6.05%
F-score: 7/9
Altman Z: 2.50
Beneish M: −2.63
Dividend safety: 58/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	11.29	13.46	13.46	22.34
P/S ratio Full definition →		2.46	2.24	2.12	1.79
P/FCF ratio Full definition →		13.00	6.36	6.24	7.02
P/Operating CF Full definition →		62.81	9.73	9.54	18.91
P/B ratio Full definition →		1.44	1.46	1.43	1.26
Price to Tangible BV Full definition →		0.00	25.20	422.81	70.02
EV/Sales Full definition →		2.73	2.47	2.39	2.11
EV/EBITDA Full definition →		13.10	13.29	13.31	11.54
EV/Operating CF Full definition →		8.30	5.02	5.03	5.55
EV/FCF Full definition →		14.45	7.02	7.03	8.25
Quick Ratio Full definition →		0.29	0.58	0.20	0.49
Current Ratio Full definition →		1.06	1.09	1.01	0.99
Net Debt/EBITDA Full definition →		2.97	10.99	6.08	7.13
Debt/Assets Full definition →		15.33%	14.66%	14.23%	16.79%
Debt/Equity Full definition →		0.27	0.26	0.25	0.31
Asset Turnover Full definition →		0.32	0.37	0.38	0.39
Operating CF/Net income Full definition →		0.00	(13.83)	0.00	13.54
Capex/Depreciation Full definition →		—	(0.47)	—	(0.30)
Interest Coverage Full definition →		16.29	(54.17)	11.72	7.49
Research and Development Expense of Revenue Full definition →		13.93%	18.84%	15.54%	18.15%
Selling, General and Administrative Expense of Revenue Full definition →		17.40%	22.59%	20.70%	20.04%
Intangible Assets out of Total Assets Full definition →		0.53	0.53	0.54	0.53
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →		(0.23)	(0.23)	(0.25)	(0.32)
Graham Number Full definition →		0.00	51.89	0.00	38.11
Earnings Yield Full definition →		8.86%	7.43%	7.43%	4.48%
Free Cash Flow Yield Full definition →		7.69%	15.73%	16.04%	14.24%
Revenue per Share Full definition →		6.32	5.78	5.46	5.98
Operating CF per Share Full definition →		0.00	4.98	0.00	2.26
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	4.98	0.00	2.26
Cash per Share Full definition →		4.27	3.55	2.69	3.09
Shareholders Equity per Share Full definition →		35.28	33.24	35.55	33.80
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		35.28	33.24	35.55	33.80
Free Cash Flow Full definition →		—	12,162.55	—	5,398.42
Working Capital Full definition →		2,264.16	2,949.56	182.59	(474.38)
Capital Expenditures Full definition →		—	(3,044.60)	—	(1,013.87)
Net Current Asset Value Full definition →		(25,971.78)	(27,315.39)	(28,928.77)	(32,521.88)
EV/EBIT Full definition →		13.10	13.29	13.31	11.54
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		11.78	12.03	11.81	9.83
Other line items
Average Receivables Full definition →		5,031.52	9,527.48	517.52	10,010.20
Average Payables Full definition →		16,860.20	8,249.59	24,674.95	8,172.42
Average Inventory Full definition →		20,032.03	10,880.71	25,263.44	11,927.86
Average Assets Full definition →		145,724.70	143,583.95	144,393.75	145,955.80
Average Common Equity Full definition →		—	80,802.47	—	79,748.01

Fold the line items

Columns are period end dates

Stockrow Weekly